Sentinel lymph node identification using contrast-enhanced ultrasound in breast cancer: review of the literature (Jul 10, 10.1007/s10396-023-01313-y, 2023)

被引：1

作者：

Omoto, Kiyoka ^{[1
]}

Futsuhara, Kazushige ^{[2
]}

Watanabe, Tamami ^{[1
]}

机构：

[1] Jichi Med Univ, Saitama Med Ctr, Dept Lab Med, 1-847 Amanuma Cho,Omiya Ku, Saitama 3308503, Japan

[2] Jichi Med Univ, Saitama Med Ctr, Dept Surg, 1-847 Amanuma Cho,Omiya Ku, Saitama 3308503, Japan

来源：

JOURNAL OF MEDICAL ULTRASONICS | 2024年 / 51卷 / 04期

关键词：

Breast cancer; Contrast-enhanced ultrasound (CEUS); Sentinel lymph node (SLN); Sonazoid; Ultrasound contrast agent (UCA);

D O I：

10.1007/s10396-024-01493-1

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

Before breast cancer surgery, sentinel lymph node (SLN) identification and biopsy using blue dye, radioisotope (RI) with a gamma probe, or a combination of the two are mainly performed. The dye-guided method requires skilled technique to make an incision in the skin and identify SLNs without damaging the lymphatic vessels. In addition, dye-induced anaphylactic shock has been reported. To use the & gamma;-probe-guided method, the facility must be able to handle RI. However, to overcome the drawbacks of these methods, Omoto et al. developed a new identification modality using contrast-enhanced ultrasound with an ultrasound contrast agent (UCA) in 2002. Since then, many basic experiments and clinical studies using various UCA have been reported. In particular, a number of studies in SLN detection using Sonazoid have been reported and are herein reviewed.

引用

页码：693 / 693

页数：1